🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

John Dick opens the Biology and Therapy of Myeloid Malignancies conference by discussing his recent paper in Blood Cancer Discovery. Read the study: brnw.ch/21wSE6h #MyeloidMalignancies25

Today at #MyeloidMalignancies25, Blood Cancer Discovery author Catriona Jamieson speaks on Stem Cell Pathways Aging and Cancer Evolution (SPACE). Check out her related paper, Hedgehog signaling in AML: Leukemia. brnw.ch/21wSEha

Blood Cancer Discovery author Tanja Gruber will speak at #MyeloidMalignancies25 today. Read her related article: Integrative Genomic Analysis of Pediatric Myeloid-Related Acute Leukemias Identifies Novel Subtypes and Prognostic Indicators. brnw.ch/21wSFdh

Review: Immune Escape of Acute Myeloid Leukemia after Transplantation brnw.ch/21wSG3Y

Cancer Hallmarks Reviews: The Role of Inflammation in the Initiation and Progression of Myeloid Neoplasms by #MyeloidMalignancies25 organizer Iannis Aifantis brnw.ch/21wSG6b

Sphingosine-1-phosphate receptor 3 potentiates inflammatory programs in normal and leukemia stem cells to promote differentiation by #MyeloidMalignancies25 speaker John Dick brnw.ch/21wSG6k

Check out this Blood Cancer Discovery article referenced in a presentation today at #MyeloidMalignancies25 Integrative Genomic Analysis of Pediatric Myeloid-Related Acute Leukemias Identifies Novel Subtypes and Prognostic Indicators brnw.ch/21wSGdu

Are you attending #MyeloidMalignancies25? Don't miss the panel discussion featuring Deputy Editor Tanya Bondar, PhD, on The Future of Scientific Publishing.

Fantastic insights from editors; Tanya Bondar (Blood Cancer Discovery), Priscilla Kelly (Science Magazine) & Alexia-Ileana Zaromytidou (Nature Cancer) ‘The future of scientific publishing’ Ross Levine Iannis Aifantis #MyeloidMalignancies25

Cancer Hallmarks Review: A View of Myeloid Transformation through the Hallmarks of Cancer by #MyeloidMalignancies25 organizer Ross Levine. brnw.ch/21wSHgn

Patient-Derived iPSCs Faithfully Represent the Genetic Diversity and Cellular Architecture of Human Acute Myeloid Leukemia by #MyeloidMalignancies25 speaker Eirini Papapetrou. brnw.ch/21wSHwj

Today at #MyeloidMalignancies25, Eirini Papapetrou presents on "How Do TET2-Mutant HSPCS Gain Their Clonal Advantage?" Read her related article recently published in Blood Cancer Discovery: brnw.ch/21wSHJ3

Don't miss the last session of #MyeloidMalignancies25, chaired by Deputy Editor Tanya Bondar, PhD. The session will include presentations on Leveraging single-cell technologies to engineer the immune system and more.

Read the article: aacrjournals.org/bloodcancerdis…

Brexucabtagene Autoleucel versus Allogeneic Hematopoietic Cell Transplantation in Relapsed and Refractory Mantle Cell Lymphoma: brnw.ch/21wSLrk

High-Dose Methotrexate, Ibrutinib, and Temozolomide in the Treatment of Newly Diagnosed Primary CNS Lymphoma: A Multicenter, Prospective Phase II Study brnw.ch/21wSP0L

Online First: Genetic and Phenotypic correlates of clinical outcomes with Venetoclax in Acute Myeloid Leukemia: The GEN-PHEN-VEN study doi.org/10.1158/2643-3…

Mutagenic impact and evolutionary influence of chemo-radiotherapy in hematologic malignancies: brnw.ch/21wSRaV

B cell receptor silencing reveals origin and dependencies of high-grade B cell lymphomas with MYC and BCL2 rearrangements: brnw.ch/21wSRcB

Recently published: Dynamics of Mutant Hematopoietic Progenitor Cells Are Not Associated with Clinical Outcomes in Multiple Myeloma doi.org/10.1158/2643-3…